Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pancera

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Surgical Oncology. Supplement|January 1, 1991
Chemotherapy for patients not benefitting from 5-fluorouracil therapyG Luporini, R Labianca, G Pancera
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Factors influencing response rates for advanced colorectal cancer chemotherapyR Labianca, G Pancera, G Luporini
Journal of Surgical Oncology. Supplement|January 1, 1993
Medical treatment of hepatocellular carcinomaG Luporini, R Labianca, G Pancera
La Radiologia Medica|June 1, 1994
[The evolution of the liver metastases from colorectal carcinoma treated with hepatic intra-arterial chemotherapy. The echographic and CT aspects]M C Castoldi, L Dellafiore, G Pancera
Tumori|April 13, 2001
[Locoregional therapy in hepatic metastases of colorectal cancer]G Pancera, S Secondino, M Mastore, et al.
Tumori|January 1, 1997
Response evaluation as the key-point in results interpretationR Labianca, G Pancera, G Dallavalle, et al.
Tumori|February 29, 1992
High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratioR Labianca, G Pancera, L Tedeschi, et al.
Minerva Medica|March 31, 1987
[Current status of the use of vitamins (A, E, C, D), folates and selenium in the chemoprevention and treatment of malignant tumors]M Clerici, U Pastorino, R Labianca, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1988
Cisplatin + 5-fluorouracil versus 5-fluorouracil alone in advanced colorectal cancer: a randomized studyR Labianca, G Pancera, B Cesana, et al.
Leukemia & Lymphoma|September 13, 2006
High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL)E Vassallo, L Di Noto, L Palmeri, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Surgical Oncology. Supplement|January 1, 1991
Chemotherapy for patients not benefitting from 5-fluorouracil therapyG Luporini, R Labianca, G Pancera
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Factors influencing response rates for advanced colorectal cancer chemotherapyR Labianca, G Pancera, G Luporini
Journal of Surgical Oncology. Supplement|January 1, 1993
Medical treatment of hepatocellular carcinomaG Luporini, R Labianca, G Pancera
La Radiologia Medica|June 1, 1994
[The evolution of the liver metastases from colorectal carcinoma treated with hepatic intra-arterial chemotherapy. The echographic and CT aspects]M C Castoldi, L Dellafiore, G Pancera
Tumori|April 13, 2001
[Locoregional therapy in hepatic metastases of colorectal cancer]G Pancera, S Secondino, M Mastore, et al.
Tumori|January 1, 1997
Response evaluation as the key-point in results interpretationR Labianca, G Pancera, G Dallavalle, et al.
Tumori|February 29, 1992
High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratioR Labianca, G Pancera, L Tedeschi, et al.
Minerva Medica|March 31, 1987
[Current status of the use of vitamins (A, E, C, D), folates and selenium in the chemoprevention and treatment of malignant tumors]M Clerici, U Pastorino, R Labianca, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1988
Cisplatin + 5-fluorouracil versus 5-fluorouracil alone in advanced colorectal cancer: a randomized studyR Labianca, G Pancera, B Cesana, et al.
Leukemia & Lymphoma|September 13, 2006
High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL)E Vassallo, L Di Noto, L Palmeri, et al.
Pageof 3